首页> 外文期刊>European Journal of Pharmacology: An International Journal >Honokiol up-regulates prostacyclin synthease protein expression and inhibits endothelial cell apoptosis.
【24h】

Honokiol up-regulates prostacyclin synthease protein expression and inhibits endothelial cell apoptosis.

机译:厚朴酚上调前列环素合成酶蛋白表达并抑制内皮细胞凋亡。

获取原文
获取原文并翻译 | 示例
           

摘要

Honokiol is a bioactive compound extracted from the Chinese medicinal herb Magnolia officinalis. We recently demonstrated that honokiol inhibited arterial thrombosis through stimulation of prostacyclin (PGI2) generation and endothelial cell protection. The current study is designed to investigate its mechanism of stimulation of PGI2 generation and cell protection. 6-keto-PGF1alpha, the stable metabolite of PGI2, in the media of rat aortic endothelial cells was measured with radioimmunoassay kits. Indomethacin, an inhibitor of cyclooxygenase (COX) and tranylcypromine, a prostacyclin synthease inhibitor were used to ascertain the target enzyme affected by honokiol. Prostacyclin synthease protein levels in endothelial cells were determined by Western blot analysis using an anti-PGI2 synthease rabbit polyclonal antibody. Flow cytometry was used to quantify the apoptotic cells and spectrophotometry was used to test the caspase-3 activity. Honokiol (0.376-37.6 microM) increased the level of 6-keto-PGF1alpha in the media of normal endothelial cells. It counteracted the inhibitory effect of tranylcypromine on the PGI2 generation, but did not influence the effect of indomethacin; evidently, honokiol up-regulated the expression of prostacyclin synthease in the endothelial cells. These effects showed perfect concentration-dependent behavior. In addition, at lower concentration (0.376-3.76 microM), honokiol significantly decreased the percentage of apoptotic endothelial cells induced by oxidized low-density lipoprotein (ox-LDL) and significantly lowered the activity of caspase-3 stimulated by ox-LDL. A high dose of honokiol (37.6 microM), however, failed to influence either of them. In conclusion, honokiol augments PGI2 generation in normal endothelial cells; its effect on PGI2 generation attributes to up-regulation of prostacyclin synthease expression; its cell protection may be correlated with its inhibition on apoptosis of endothelial cells. These findings have partly revealed the molecular mechanism of honokiol oninhibiting arterial thrombosis.
机译:厚朴酚是从中草药木兰中提取的生物活性化合物。我们最近证明,厚朴酚通过刺激前列环素(PGI2)生成和内皮细胞保护来抑制动脉血栓形成。当前的研究旨在研究其刺激PGI2生成和细胞保护的机制。用放射免疫分析试剂盒测量了大鼠主动脉内皮细胞培养基中6-酮-PGF1α(PGI2的稳定代谢产物)的含量。使用吲哚美辛(一种环氧合酶(COX)的抑制剂)和反式环丙胺(一种前列环素合成酶抑制剂)来确定受厚朴酚影响的目标酶。使用抗PGI2合成酶兔多克隆抗体通过蛋白质印迹分析确定内皮细胞中前列环素合成酶蛋白的水平。流式细胞术用于定量凋亡细胞,分光光度法用于测试caspase-3活性。厚朴酚(0.376-37.6 microM)增加了正常内皮细胞培养基中6-酮-PGF1alpha的水平。它抵消了反式环丙胺对PGI2的抑制作用,但不影响消炎痛的作用。显然,厚朴酚上调了内皮细胞中前列环素合成酶的表达。这些效果显示出完美的浓度依赖性行为。此外,在较低浓度(0.376-3.76 microM)下,厚朴酚显着降低了由氧化的低密度脂蛋白(ox-LDL)诱导的凋亡内皮细胞的百分比,并显着降低了由ox-LDL刺激的caspase-3的活性。但是,高剂量的厚朴酚(37.6 microM)无法影响它们中的任何一个。总之,厚朴酚可增加正常内皮细胞中PGI2的产生。它对PGI2生成的影响归因于前列环素合成酶表达的上调;其细胞保护作用可能与其对内皮细胞凋亡的抑制作用有关。这些发现部分揭示了厚朴酚抑制动脉血栓形成的分子机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号